Morphine sulphate
(OOZBZVAQKFGLOL-VYKNHSEDSA-N)
Structure
- SMILES
- OS(=O)(=O)O.O[C@H]1C=C[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O
- Molecular Formula:
- C17H21NO7S
- Molecular Weight:
- 383.416
- Log P:
- 1.5640
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 4
- TPSA:
- 135.91
- CAS Number(s):
- N/A
Synonym(s)
1.
Morphine sulphate
External Link(s)
| PubChem Compound | 5464280 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug Dependence | FAERS: 20 | US FAERS | |
| 2 | Drug abuse | FAERS: 16 | US FAERS | |
| 3 | Poisoning | FAERS: 15 | US FAERS | |
| 4 | Toxicity to various agents | FAERS: 7 | US FAERS | |
| 5 | Overdose | FAERS: 6 | US FAERS | |
| 6 | Drug ineffective | FAERS: 4 | US FAERS | |
| 7 | Hypersensitivity | FAERS: 4 | US FAERS | |
| 8 | Accidental overdose | FAERS: 3 | US FAERS | |
| 9 | Bradycardia | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 10 | Completed Suicide | FAERS: 3 | US FAERS | |
| 11 | Hypogonadism | FAERS: 3 | US FAERS | |
| 12 | Somnolence | FAERS: 3 | US FAERS | |
| 13 | Drug administration error | FAERS: 2 | US FAERS | |
| 14 | Drug diversion | FAERS: 2 | US FAERS | |
| 15 | Drug withdrawal syndrome | FAERS: 2 | US FAERS | |
| 16 | Respiratory arrest | FAERS: 2 | US FAERS | |
| 17 | Schizophrenia | FAERS: 2 | US FAERS | |
| 18 | Unresponsive to stimuli | FAERS: 2 | US FAERS | |
| 19 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 20 | Asthenia | FAERS: 1 | US FAERS | |
| 21 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 22 | Constipation | FAERS: 1 | US FAERS | |
| 23 | Dehydration | FAERS: 1 | US FAERS | |
| 24 | Device computer issue | FAERS: 1 | US FAERS | |
| 25 | Disorientation | FAERS: 1 | US FAERS | |
| 26 | Euthanasia | FAERS: 1 | US FAERS | |
| 27 | Fatigue | FAERS: 1 | US FAERS | |
| 28 | Hypopituitarism | FAERS: 1 | US FAERS | |
| 29 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 30 | Injection site erythema | FAERS: 1 | US FAERS | |
| 31 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 32 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 33 | Intentional medical device removal by patient | FAERS: 1 | US FAERS | |
| 34 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 35 | Local reaction | FAERS: 1 | US FAERS | |
| 36 | Malaise | FAERS: 1 | US FAERS | |
| 37 | Mastectomy | FAERS: 1 | US FAERS | |
| 38 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 39 | Medication Error | FAERS: 1 | US FAERS | |
| 40 | Myoclonus | FAERS: 1 | US FAERS | |
| 41 | Nausea | FAERS: 1 | US FAERS | |
| 42 | No adverse event | FAERS: 1 | US FAERS | |
| 43 | Pallor | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 44 | Pancreatitis | FAERS: 1 | US FAERS | |
| 45 | Phlebitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 46 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 47 | Product contamination physical | FAERS: 1 | US FAERS | |
| 48 | Product quality issue | FAERS: 1 | US FAERS | |
| 49 | Product selection error | FAERS: 1 | US FAERS | |
| 50 | Psychomotor skills impaired | FAERS: 1 | US FAERS | |
| 51 | Skin reaction | FAERS: 1 | US FAERS | |
| 52 | Suicide attempt | FAERS: 1 | US FAERS | |
| 53 | Swelling | FAERS: 1 | US FAERS | |
| 54 | Syringe issue | FAERS: 1 | US FAERS | |
| 55 | Tremor | FAERS: 1 | US FAERS | |
| 56 | Urticaria | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 57 | Vomiting | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 58 | Weight decreased | FAERS: 1 | US FAERS | |
| 59 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 60 | Abdominal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 61 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 62 | Chest discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 63 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 64 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 65 | Erythema | Canada Vigilance: 4 | Canada Vigilance | |
| 66 | Hypotension | Canada Vigilance: 1 | Canada Vigilance | |
| 67 | Injection Site Reaction | Canada Vigilance: 4 | Canada Vigilance | |
| 68 | Injection site pain | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Pharyngeal swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 70 | Pruritus | Canada Vigilance: 7 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.